Filing Details
- Accession Number:
- 0001415889-25-012532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-09 16:59:48
- Reporting Period:
- 2025-05-07
- Filing Date:
- 2025-05-09
- Accepted Time:
- 2025-05-09 16:59:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals International Plc | KNSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1464583 | R Michael Megna | 23 Old Bond Street, Third Floor London X0 W1S 4PZ | Chief Accounting Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Acquisiton | 2025-05-07 | 229 | $8.83 | 32,775 | No | 4 | M | Direct | |
| Class A Ordinary Share | Acquisiton | 2025-05-07 | 2,998 | $15.50 | 35,773 | No | 4 | M | Direct | |
| Class A Ordinary Share | Acquisiton | 2025-05-07 | 14,420 | $11.97 | 50,193 | No | 4 | M | Direct | |
| Class A Ordinary Share | Disposition | 2025-05-07 | 17,647 | $26.69 | 32,546 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Ordinary Share | Share Option | Disposition | 2025-05-07 | 229 | $0.00 | 229 | $8.83 |
| Class A Ordinary Share | Share Option | Disposition | 2025-05-07 | 2,998 | $0.00 | 2,998 | $15.50 |
| Class A Ordinary Share | Share Option | Disposition | 2025-05-07 | 14,420 | $0.00 | 14,420 | $11.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 16,002 | No | 4 | M | Direct | ||
| 17,040 | 2032-08-31 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 24, 2024.
- The option is fully vested and exercisable.
- The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.
Billionaire Hedge Funds
